TY - JOUR
T1 - Rare case of polymicrobial keratitis with balantidium coli
AU - Hazarika, Manali
AU - Vijaya Pai, H.
AU - Khanna, Vinay
AU - Reddy, Harish
AU - Tilak, Kriti
AU - Chawla, Kiran
N1 - Publisher Copyright:
© 2016 Wolters Kluwer Health, Inc.
PY - 2016/6/30
Y1 - 2016/6/30
N2 - Purpose: To report a rare case of polymicrobial keratitis due to Balantidium coli and gram-negative bacteria, Pseudomonas aeruginosa and Klebsiella pneumoniae, in a soft contact lens (CL) wearer. Methods: We report a case of CL-related keratitis due to B. coli, P. aeruginosa, and K. pneumoniae. Results: The culture of the corneal scrapings, the CL cleaning solution, and the CL revealed the growth of a rare ciliated parasite, B. coli, along with gram-negative bacteria, namely, P. aeruginosa and K. pneumoniae. The patient was successfully treated with topical broad-spectrum antibiotics and intravenous metronidazole. Conclusions: Polymicrobial keratitis has seldom been reported with B. coli as the causative agent. CL wear can be a risk factor for this infection. Treatment with topical antibiotics may not suffice, and the intravenous route of antiprotozoal drugs may be a useful adjunct. Increasing awareness, early diagnosis, and treatment may improve the final visual outcome.
AB - Purpose: To report a rare case of polymicrobial keratitis due to Balantidium coli and gram-negative bacteria, Pseudomonas aeruginosa and Klebsiella pneumoniae, in a soft contact lens (CL) wearer. Methods: We report a case of CL-related keratitis due to B. coli, P. aeruginosa, and K. pneumoniae. Results: The culture of the corneal scrapings, the CL cleaning solution, and the CL revealed the growth of a rare ciliated parasite, B. coli, along with gram-negative bacteria, namely, P. aeruginosa and K. pneumoniae. The patient was successfully treated with topical broad-spectrum antibiotics and intravenous metronidazole. Conclusions: Polymicrobial keratitis has seldom been reported with B. coli as the causative agent. CL wear can be a risk factor for this infection. Treatment with topical antibiotics may not suffice, and the intravenous route of antiprotozoal drugs may be a useful adjunct. Increasing awareness, early diagnosis, and treatment may improve the final visual outcome.
UR - http://www.scopus.com/inward/record.url?scp=84983550761&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84983550761&partnerID=8YFLogxK
U2 - 10.1097/ICO.0000000000000982
DO - 10.1097/ICO.0000000000000982
M3 - Article
C2 - 27560034
AN - SCOPUS:84983550761
SN - 0277-3740
VL - 35
SP - 1665
EP - 1667
JO - Cornea
JF - Cornea
IS - 12
ER -